Drug Shortage Report for IRBESARTAN-HCTZ
Report ID | 14365 |
Drug Identification Number | 02365189 |
Brand name | IRBESARTAN-HCTZ |
Common or Proper name | IRBESARTAN-HCTZ |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
Strength(s) | 25MG 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-08-30 |
Estimated end date | |
Actual end date | 2018-05-08 |
Shortage status | Resolved |
Updated date | 2018-05-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2018-05-09 | English | Compare |
v20 | 2018-05-08 | French | Compare |
v19 | 2018-05-08 | English | Compare |
v18 | 2018-04-25 | French | Compare |
v17 | 2018-04-25 | English | Compare |
v16 | 2018-02-05 | French | Compare |
v15 | 2018-02-05 | English | Compare |
v14 | 2018-02-05 | French | Compare |
v13 | 2018-02-05 | English | Compare |
v12 | 2017-10-30 | French | Compare |
v11 | 2017-10-30 | English | Compare |
v10 | 2017-09-01 | French | Compare |
v9 | 2017-09-01 | English | Compare |
v8 | 2017-09-01 | English | Compare |
v7 | 2017-08-24 | French | Compare |
v6 | 2017-08-24 | English | Compare |
v5 | 2017-08-24 | English | Compare |
v4 | 2017-08-15 | French | Compare |
v3 | 2017-08-15 | English | Compare |
v2 | 2017-06-29 | French | Compare |